Gurugram-based startup Genes2Me has recently launched its molecular biology product range, to accelerate research in the field of Biosciences, at Medica Germany. The range contains high efficient Fantom-DNA polymerase for precise amplification of target genes for gene-expression studies.

Enzyme technology, Cloning, Next-generation sequencing, and polymerase chain reaction are among the Genes2me product categories (PCR). The Fantom High-Fidelity PCR DNA polymerase considerably improves the PCR test's sensitivity, making it a viable cornerstone for cloning technology.

Genes2Me has been recognised as a reliable and leading firm for developing COVID-19 testing kits and now with its launch of a variety of products, the company is expanding its footprints in manufacturing molecular biology products.

Whereas molecular biology is essential for understanding perplexing interactions between molecules at the subcellular level, Next Generation Sequencing (NGS) greatly aids in the discovery of complex gene arrangements in species. Genes2me was inspired to build a suite of tools to facilitate NGS-based studies across the subcontinent and beyond after seeing a stunning use of NGS in COVID-19 research.